Skip to main content
Fig. 3 | EJNMMI Research

Fig. 3

From: 18F-C2Am: a targeted imaging agent for detecting tumor cell death in vivo using positron emission tomography

Fig. 3

Biodistribution profile of 18F-C2Am, 2 h post-administration. Mice bearing Colo205 tumors were treated with MEDI3039 (closed bars; 0.4 mg/kg, i.v., 24 h) or vehicle (open bars). 18F-C2Am was injected (1 MBq, i.v.) and tissues collected post-mortem 2 h following administration. Fraction of injected activity per gram of tissue (IA/g, %) (mean ± SEM, n = 5 per treatment group). Two-tailed, t test, unequal variance. *P < 0.05

Back to article page